Taken together, these observations suggest that although c-MYC gene copy-number variation and amplification have been commonly reported in ovarian cancer, a relationship between c-MYC gene aberrations and prognostic or clinicopathological significance has not been clearly established. Here, MYC is linked to ovarian carcinoma.